NSC |
Compound |
Enrichment |
Correlation |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0135714101922724 |
0.45110294 |
NSC 753598 |
Null |
0.0135714101922724 |
0.31264076 |
NSC 762346 |
Null |
0.0135714101922724 |
0.21582329 |
NSC 762908 |
2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one |
0.0135714101922724 |
0.29670288 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0139796580235792 |
0.16452911 |
NSC 13151 |
Null |
0.0139796580235792 |
0.24282747 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0139796580235792 |
0.25864822 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0139796580235792 |
0.40393055 |
NSC 18805 |
.gamma.-Thujaplicine |
0.0139796580235792 |
0.51182902 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0139796580235792 |
0.29309079 |